Gary H. Lyman – författare

The therapeutic landscape in oncology has undergone momentous changes in recent years. The treatment options for gastrointestinal (GI) cancers, in particular, have increased with the introduction of novel pharmacological and other treatment modalities. Researchers have gleaned important insights into the molecular biology, pathophysiology and key features of the most prevalent GI cancers, including colorectal, pancreatic and liver. While these advances have resulted in improvements for many GI cancer patients, the emerging complexities and challenges have necessitated the revision of major U.S. and international staging, diagnosis, and treatment guidelines for GI cancers. Part of the Oxford American Mini-Handbook series, this concise yet comprehensive volume provides oncologists and other healthcare professionals with essential, evidence-based guidance on the diagnosis and treatment of all major GI malignancies, including colorectal, pancreatic, liver and esophageal cancers.SERIES OVERVIEWThe Oxford American Mini-Handbooks are a series of concisely-formatted adaptations of Oxford American Handbooks. They provide a focused and succinct summary on a specific area of a particular discipline, serving as a portable, easily accessible resource at the point of care. These smaller volumes capture the essentials of assessment and treatment in an exceptionally affordable and more clinically relevant format. Featuring useful tables and bulleted lists, these books provide a readily available resource to specialists and general practitioners alike.

In recent years, there has been considerable progress in our understanding of the treatment and diagnosis of cancer, leading to the development and availability of an increasing array of novel therapies. Concurrently, there has also been an increase in understanding and insight gained into effective management strategies in cancer supportive care which have enabled oncologists to reduce the adverse impact of cancer and its treatment. However, challenges, controversies and educational gaps remain. This concise yet comprehensive pocket guide provides oncologists and other healthcare professionals with essential, evidence-based guidance on the all major elements related to cancer supportive care, including pain management and end-of-life care. Edited by a world renowned oncologist, this volume outlines complex management issues common in cancer supportive care, including metabolic emergencies, febrile neutropenia, and spinal cord compression.SERIES OVERVIEWThe Oxford American Mini-Handbooks are a series of concisely-formatted adaptations of Oxford American Handbooks. They provide a focused and succinct summary on a specific area of a particular discipline, serving as a portable, easily accessible resource at the point of care. These smaller volumes capture the essentials of assessment and treatment in an exceptionally affordable and more clinically relevant format. Featuring useful tables and bulleted lists, these books provide a readily available resource to specialists and general practitioners alike.

The therapeutic landscape in oncology has undergone momentous changes in recent years. The treatment options for gastrointestinal (GI) cancers, in particular, have increased with the introduction of novel pharmacological and other treatment modalities. Researchers have gleaned important insights into the molecular biology, pathophysiology and key features of the most prevalent GI cancers, including colorectal, pancreatic and liver. While these advances have resulted in improvements for many GI cancer patients, the emerging complexities and challenges have necessitated the revision of major U.S. and international staging, diagnosis, and treatment guidelines for GI cancers. Part of the Oxford American Mini-Handbook series, this concise yet comprehensive volume provides oncologists and other healthcare professionals with essential, evidence-based guidance on the diagnosis and treatment of all major GI malignancies, including colorectal, pancreatic, liver and esophageal cancers.SERIES OVERVIEWThe Oxford American Mini-Handbooks are a series of concisely-formatted adaptations of Oxford American Handbooks. They provide a focused and succinct summary on a specific area of a particular discipline, serving as a portable, easily accessible resource at the point of care. These smaller volumes capture the essentials of assessment and treatment in an exceptionally affordable and more clinically relevant format. Featuring useful tables and bulleted lists, these books provide a readily available resource to specialists and general practitioners alike.

Genitourinary cancers are comprised of physiologically complex and challenging-to-treat tumor types. In recent years, clinical and basic science research has resulted in many major advances in understanding the pathophysiology and management strategies of these diseases. In addition to the approval by the FDA of new pharmacological agents, the newly-gleaned insights and changing treatment strategies have led to the revision of current diagnosis and treatment guidelines. However, challenges, controversies and educational gaps remain. This succinct yet comprehensive volume provides oncologists and other healthcare professionals with essential, evidence-based guidance on all the major elements related to the diagnosis and treatment of the major types of genitourinary cancers. Edited by a world renowned oncologist, this volume outlines the general pathophysiology as well as pharmacological and other treatment approaches.SERIES OVERVIEWThe Oxford American Mini-Handbooks are a series of concisely-formatted adaptations of Oxford American Handbooks. They provide a focused and succinct summary on a specific area of a particular discipline, serving as a portable, easily accessible resource at the point of care. These smaller volumes capture the essentials of assessment and treatment in an exceptionally affordable and more clinically relevant format. Featuring useful tables and bulleted lists, these books provide a readily available resource to specialists and general practitioners alike.

The Oxford American Handbook of Oncology is the essential reference for medical students, residents, and clinical oncologists seeking a current, portable resource on the delivery of sophisticated cancer care. Chapters focus on the immediate information needs in clinical decision making including treatment choices. Algorithms, best practice guidelines, highlighted tables, and targeted lists of landmark references enhance the concise text. For the second edition biologic therapies and therapeutic regimens and options and clinical trial information have been rigorously updated throughout.

The Oxford American Handbook of Oncology is the essential reference for medical students, residents, and clinical oncologists seeking a current, portable resource on the delivery of sophisticated cancer care. Chapters focus on the immediate information needs in clinical decision making including treatment choices. Algorithms, best practice guidelines, highlighted tables, and targeted lists of landmark references enhance the concise text. For the second edition biologic therapies and therapeutic regimens and options and clinical trial information have been rigorously updated throughout.

The therapeutic landscape in oncology has undergone momentous changes in recent years. The treatment options for gastrointestinal (GI) cancers, in particular, have increased with the introduction of novel pharmacological and other treatment modalities. Researchers have gleaned important insights into the molecular biology, pathophysiology and key features of the most prevalent GI cancers, including colorectal, pancreatic and liver. While these advances have resulted in improvements for many GI cancer patients, the emerging complexities and challenges have necessitated the revision of major U.S. and international staging, diagnosis, and treatment guidelines for GI cancers. Part of the Oxford American Mini-Handbook series, this concise yet comprehensive volume provides oncologists and other healthcare professionals with essential, evidence-based guidance on the diagnosis and treatment of all major GI malignancies, including colorectal, pancreatic, liver and esophageal cancers.SERIES OVERVIEWThe Oxford American Mini-Handbooks are a series of concisely-formatted adaptations of Oxford American Handbooks. They provide a focused and succinct summary on a specific area of a particular discipline, serving as a portable, easily accessible resource at the point of care. These smaller volumes capture the essentials of assessment and treatment in an exceptionally affordable and more clinically relevant format. Featuring useful tables and bulleted lists, these books provide a readily available resource to specialists and general practitioners alike.

The Oxford American Handbook of Oncology is the essential reference for medical students, residents, and clinical oncologists seeking a current, portable resource on the delivery of sophisticated cancer care. Chapters focus on the immediate information needs in clinical decision making including treatment choices. Algorithms, best practice guidelines, highlighted tables, and targeted lists of landmark references enhance the concise text. For the second edition biologic therapies and therapeutic regimens and options and clinical trial information have been rigorously updated throughout.

Considering the impact of translational breakthroughs on the early detection, diagnosis, prevention, and treatment of breast cancer, this all-encompassing guide collects cutting-edge research on the most promising strategies and agents likely to impact the management and long-term outcomes of women with breast cancer. This book will provide current information on rapidly evolving translational therapies, as well as improved strategies for the selection of patients for these treatments.

Considering the impact of translational breakthroughs on the early detection, diagnosis, prevention, and treatment of breast cancer, this all-encompassing guide collects cutting-edge research on the most promising strategies and agents likely to impact the management and long-term outcomes of women with breast cancer. This book will provide current

Written with a broader perspective and knowledge, Cancer Supportive Care: Advances in Therapeutic Strategies presents state-of-the-art management options for the full range of symptoms, toxicities, and complications experienced by cancer patients. In addition to "bread and butter" topics such as pain control and nausea and vomiting, the book contai

Considering the impact of translational breakthroughs on the early detection, diagnosis, prevention, and treatment of breast cancer, this all-encompassing guide collects cutting-edge research on the most promising strategies and agents likely to impact the management and long-term outcomes of women with breast cancer. This book will provide current

Written with a broader perspective and knowledge, Cancer Supportive Care: Advances in Therapeutic Strategies presents state-of-the-art management options for the full range of symptoms, toxicities, and complications experienced by cancer patients. In addition to "bread and butter" topics such as pain control and nausea and vomiting, the book contains unique, ground-breaking discussions of symptom measurement, the role of growth factors, and late effects and cancer survivorship.Written by key opinion leaders in the field, Cancer Supportive Care: Advances in Therapeutic Strategies: assembles and synthesizes state-of-the-art information into one convenient resource, helping busy clinicians learn the most effective supportive care strategies availablediscusses emerging therapies and approachescovers topics not included in other cancer supportive care books, such as measurement of symptoms, growth factors, thromboembolism, skeletal complications, fatigue, the elderly cancer patient, cancer survivorship, and alternative and integrative therapies